DNCE Could Improve NDA Process With More Staffing, Sponsor Meetings

In an interview with "The Tan Sheet," Andrea Leonard-Segal, M.D., director of FDA's Division of Nonprescription Clinical Evaluation, discussed improving the new drug application process for over-the-counter products

More from Archive

More from Pink Sheet